The Role of Cocaine- and Amphetamine-Regulated Transcript (CART) in Cancer: A Systematic Review

Maja Owe-Larsson1, Jan Pawłasek1, Tomasz Piecha2

  • 1Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.

Insights

The cocaine- and amphetamine-regulated transcript (CART) protein is involved in cancer development and progression. CART may serve as a biomarker and therapeutic target in various neoplastic disorders.

Area of Science:

  • Molecular Biology
  • Oncology
  • Neuroscience

Background:

  • The cocaine- and amphetamine-regulated transcript (CART) neuropeptide, encoded by the CARTPT gene, has diverse functions including behavioral modification, pain sensitivity, and antioxidant activity.
  • The CART peptide receptor GPR160 has been linked to cancer pathogenesis, but the precise role of CART protein in neoplasm development is not fully understood.

Approach:

  • A systematic review was conducted, analyzing 19 publications from Scopus, PubMed, Web of Science, and Medline Complete databases.
  • The review focused on studies investigating the association between CART and various types of cancer.

Key Points:

  • CART is expressed in multiple cancers, including breast cancer and neuroendocrine tumors (NETs).
  • CART shows potential as a biomarker for breast cancer, stomach adenocarcinoma, glioma, and certain NETs.
  • In cancer cell lines, CART functions as an oncogene, promoting cell survival by activating the ERK pathway, inhibiting apoptosis, and increasing cyclin D1 levels.
  • CART has been observed to protect breast cancer cells from tamoxifen-induced death.

Conclusions:

  • The data strongly support CART's involvement in cancer pathogenesis.
  • CART activity presents potential new avenues for diagnostic and therapeutic strategies in neoplastic disorders.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K